The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of outcomes and genomic alterations (GA) in combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA).
 
Jaime Haro-Silerio
No Relationships to Disclose
 
Daniel Aaron Fox
No Relationships to Disclose
 
Deepak Bhamidipati
No Relationships to Disclose
 
Zishuo Ian Hu
No Relationships to Disclose
 
Eugene Jon Koay
No Relationships to Disclose
 
Ethan B. Ludmir
Employment - Alaunos Therapeutics (I)
 
Hop Sanderson Tran Cao
No Relationships to Disclose
 
Jean-Nicolas Vauthey
No Relationships to Disclose
 
Timothy E. Newhook
No Relationships to Disclose
 
Ching-Wei D. Tzeng
Honoraria - PanTher Therapeutics
Research Funding - Sirtex Medical (Inst)
 
Yun Shin Chun
No Relationships to Disclose
 
Armeen Mahvash
No Relationships to Disclose
 
Zeyad Metwalli
No Relationships to Disclose
 
Peiman Habibollahi
No Relationships to Disclose
 
Veronica L. Cox
No Relationships to Disclose
 
Hyunseon Kang
No Relationships to Disclose
 
Deyali Chatterjee
No Relationships to Disclose
 
Ahmed Omar Kaseb
Honoraria - AstraZeneca; Bayer Health; Bristol-Myers Squibb; Eisai; Exelixis; Genentech/Roche; Merck
Consulting or Advisory Role - AstraZeneca; Bayer Health; Bristol-Myers Squibb; Eisai; Exelixis; Genentech/Roche; Merck
Research Funding - Adaptimmune (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Hengrui Pharmaceutical (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Eisai; Exelixis; Genentech/Roche; Merck
 
Milind M. Javle
Honoraria - AstraZeneca/MedImmune; EMD Serono/Merck; Incyte; Merck; QED Therapeutics; TransThera Biosciences
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; EMD Serono; incyte; Merck; Mundipharma; oncosil; QED Therapeutics
Other Relationship - Bayer; BeiGene; Incyte; Merck; Merck Serono; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen
 
Sunyoung S. Lee
No Relationships to Disclose